Actithera News and Activities

Acquisition, funding and merger involving Actithera.

• Actithera has just announced a $75 Million fundraising (posted on July 10 2025).

View the org chart displaying its 10 main executives

Most searched biographies at Actithera

• Andreas Goutopoulos, Chief Executive Officer
• Therese Liechtenstein, Director
• Debbie Dumont, Director

Popular executive movements at Actithera

• Darshan Dalal has joined the company as Chief Medical Officer  (posted on December 4 2025).
• Dimitrios Mantzilas has joined the company as Chief Technology Officer and Site Head, Actithera Oslo  (posted on November 6 2025).

Create your alert
to follow the executive moves at Actithera.

Actithera has 2,422 competitors including Lonza (Switzerland), Eurofins (Luxembourg) and Vertex Pharmaceuticals (United States (USA)).

Popular M&A news in Biotechnology

• BridgeBio has just announced a $1,000 Million fundraising (posted on July 2 2026).
• Flare Therapeutics has just announced a $85 Million fundraising (posted on July 2 2026).
• Ipsen has announced the acquisition of Memo Therapeutics  (posted on July 1 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Carl Gordon - Director at Odyssey Therapeutics
• Robert Gould - Board Member at Fulcrum Therapeutics

Learn more about the Biotechnology industry

Press releases by Actithera

• Actithera | News and Publications

Social media about Actithera

• Actithera on Wikipedia, Google News & Yahoo Finance
• Actithera on LinkedIn, X (Twitter) & YouTube